Cargando…
Serological assays for emerging coronaviruses: Challenges and pitfalls
More than a decade after the emergence of severe acute respiratory syndrome coronavirus (SARS-CoV) in 2002/2003 the occurrence of a novel CoV termed Middle East respiratory syndrome (MERS) CoV challenges researchers and public health authorities. To control spread and finally contain novel viruses,...
Autores principales: | Meyer, Benjamin, Drosten, Christian, Müller, Marcel A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier B.V.
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7114385/ https://www.ncbi.nlm.nih.gov/pubmed/24670324 http://dx.doi.org/10.1016/j.virusres.2014.03.018 |
Ejemplares similares
-
Comparison of Serologic Assays for Middle East Respiratory Syndrome Coronavirus
por: Harvey, Ruth, et al.
Publicado: (2019) -
Plaque assay for human coronavirus NL63 using human colon carcinoma cells
por: Herzog, Petra, et al.
Publicado: (2008) -
Micronucleus Assay: Pitfalls and Challenges
por: Naderi, Noushin Jalayer
Publicado: (2020) -
Serologic Assessment of Possibility for MERS-CoV Infection in Equids
por: Meyer, Benjamin, et al.
Publicado: (2015) -
Presence of Middle East respiratory syndrome coronavirus antibodies in Saudi Arabia: a nationwide, cross-sectional, serological study
por: Müller, Marcel A, et al.
Publicado: (2015)